Emgality Galcanezumab 120 mg

Get a Price/Quote

MOQ : 10 Pieces

Emgality Galcanezumab 120 mg Specification

Indication
Migraine prophylaxis in adults

Salt Composition
Galcanezumab 120 mg

Dosage Form
Injection

Life Span
Check expiry date on package; typically 12-24 months from manufacturing

Origin of Medicine
Imported; available in multiple countries including the US, UK, Europe, Canada, and Australia

Pacakaging (Quantity Per Box)
1 pre-filled pen per box

Packaging Type
Carton box containing one pre-filled pen

Brand Name
Emgality

Drug Type
Prescription Only Medicine (Rx)

Ingredients
Galcanezumab

Physical Form
Injection (Pre-filled Pen)

Function
Prevention of migraine headaches

Recommended For
Adults with migraine

Dosage
120 mg once monthly after initial loading dose as prescribed by physician

Dosage Guidelines
As directed by healthcare professional

Suitable For
Adults

Quantity
One pre-filled pen

Storage Instructions
Store in refrigerator (2C - 8C). Do not freeze. Keep away from direct light.

Caution
For use under medical supervision only

Therapeutic Area
Neurology/Headache Management

Marketed Countries
Canada, EU, UK, USA, Australia

Instructions for Use
Detailed leaflet provided with packaging

Administration Route
Subcutaneous injection

Approval Status
FDA and EMA approved

Needle Included
Yes, attached to pre-filled pen

Colour
Clear to slightly yellow solution

Shelf Life
Check individual carton; generally up to 24 months from date of manufacture

Primary Packaging Material
Plastic pre-filled pen in sealed blister

Patient Category
Not for pediatric use

Emgality Galcanezumab 120 mg About

Emgality Galcanezumab 120 mg is a customizable and popular choice for migraine prophylaxis, delivering stellar performance with its spectacular efficacy. Administered via a subcutaneous injection, the solution ranges from clear to slightly yellow and is presented in a sterling, invincible plastic pre-filled pen, ensuring both convenience and safety. Each package contains one needle-attached pen designed for adult usage only-pediatric use is not advised. Emgality is FDA and EMA approved, marketed across Canada, EU, UK, USA, and Australia, and must be stored refrigerated. It's an ephemeral yet powerful tool for managing migraine cycles, offering reliable, long-lasting relief.

Competitive Advantages and Features of Emgality

Emgality Galcanezumab 120 mg stands out for its user-friendly pre-filled pen, making administration seamless and efficient. The device is equipped with a precision-engineered needle and provides consistent dosage delivery for optimal therapeutic effect. Usage is straightforward: inject once monthly after the prescribed loading dose. Notably, the pen is designed for adults only and offers the flexibility of self-administration under medical guidance, establishing it as an invincible solution for migraine prevention.

Certifications, Market Scope, and Order Terms

FDA and EMA certified, Emgality ensures a high standard of safety and efficacy. Available in several major markets-including the US, Canada, Europe, the UK, and Australia-it meets the needs of a sterling international clientele. Order processing is seamless, with prompt dispatch to ensure minimal expenditure. We guarantee the lowest price for genuine, imported Emgality. Transactions adhere to flexible payment terms, accommodating both institutional and individual procurement with efficiency and transparency.

FAQ's of Emgality Galcanezumab 120 mg:

Q: How should Emgality Galcanezumab 120 mg be administered?

A: Emgality is administered as a subcutaneous injection using the included pre-filled pen, once monthly after the initial loading dose, always as directed by a healthcare professional.

Q: What are the main benefits of using Emgality for migraine prevention?

A: Emgality offers effective, consistent migraine prevention in adults, with the convenience of a pre-measured, easy-to-use pen and minimal preparation. Its invincible results help reduce the frequency of migraine attacks.

Q: When should Emgality not be used?

A: Emgality is not for pediatric use. It should only be used under medical supervision, and you must consult your healthcare provider regarding its suitability, especially if you have specific contraindications.

Q: Where is Emgality available and is it FDA/EMA approved?

A: Emgality is approved by both the FDA and EMA and is marketed in Canada, the EU, UK, USA, and Australia, offering global standards in migraine management.

Q: What is the shelf life and storage process for Emgality?

A: The shelf life is generally up to 24 months from manufacture. Always check the expiry date on the package. Emgality must be stored in a refrigerator (2C - 8C), not frozen, and kept away from direct light.

Q: How do I know if Emgality is right for my migraine management?

A: Consult your healthcare provider to discuss your medical history, symptoms, and the potential benefits of Emgality to determine if it's suitable for your migraine prophylaxis.

Tell us about your requirement